MIGHT TREATMENT OF HYPERCHOLESTEROLEMIA INCREASE NONCARDIAC MORTALITY

被引：143

作者：

OLIVER, MF

机构：

[1] Wynn Institute for Metabolic Research, London, NW89SQ

来源：

关键词：

D O I：

10.1016/0140-6736(91)93208-Q

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1529 / 1531

页数：3

共 23 条

[1] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN
CANNER, PL
BERGE, KG
WENGER, NK
STAMLER, J
FRIEDMAN, L
PRINEAS, RJ
FRIEDEWALD, W
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) : 1245 - 1255
[2] CARLSON LA, 1988, ACTA MED SCAND, V223, P405
[3] SUPPRESSION OF LYMPHOID-CELL FUNCTION-INVITRO BY INHIBITION OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE BY LOVASTATIN
CUTTS, JL
BANKHURST, AD
[J]. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1989, 11 (08): : 863 - 869
[4] DAYTON S, 1969, CIRCULATION S2, V39, P1
[5] EDERER F, 1971, LANCET, V2, P203
[6] HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE
FRICK, MH
ELO, O
HAAPA, K
HEINONEN, OP
HEINSALMI, P
HELO, P
HUTTUNEN, JK
KAITANIEMI, P
KOSKINEN, P
MANNINEN, V
MAENPAA, H
MALKONEN, M
MANTTARI, M
NOROLA, S
PASTERNACK, A
PIKKARAINEN, J
ROMO, M
SJOBLOM, T
NIKKILA, EA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (20) : 1237 - 1245
[7] HEADY JA, 1980, LANCET, V2, P379
[8] HJERMANN I, 1990, ATHER REV, V21, P103
[9] HJERMANN I, 1981, LANCET, V2, P1303
[10] PREVENTION OF CORONARY-ARTERY DISEASE - A MEDICAL IMPERATIVE
LEAF, A
RYAN, TJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (20) : 1416 - 1419